Get started
Author

Muh‐Hwa Yang

Observed names: M. J. Yang, Muh-Hwa Yang, Muh‑Hwa Yang, Yang, Muh-Hwa
ORCID: 0000-0002-8918-1244
Observed ORCID: 0000-0002-8918-1244
OpenAlex ID: A5003861667
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
2019 · Barbara Burtness, Kevin J Harrington, et al. · The Lancet · 3,502
PDF
Treatment for T1-2 Oral Squamous Cell Carcinoma with or Without Perineural Invasion: Neck Dissection and Postoperative Adjuvant Therapy
2011 · Shyh-Kuan Tai, Wing-Yin Li, et al. · Annals of Surgical Oncology · 90
A regulatory BMI 1/let‐7i/ ERK 3 pathway controls the motility of head and neck cancer cells
2017 · Lobna Elkhadragy, Minyi Chen, et al. · Molecular Oncology · 43
PDF
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2025 · Jérôme Fayette, Lisa Licitra, et al. · Clinical Cancer Research · 39
PDF
Epithelial‐mesenchymal transition softens head and neck cancer cells to facilitate migration in 3D environments
2018 · Yin‐Quan Chen, Hsin‐Yi Lan, et al. · Journal of Cellular and Molecular Medicine · 37
PDF
Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia
1992 · Po-Min Chen, Chueh-Chuan Yen, et al. · International Journal of Oncology · 32
PDF
Correlation between HGF/c-Met and Notch1 signaling pathways in human gastric cancer cells
2018 · Kuo-Hung Huang, I-Cheng Sung, et al. · Oncology Reports · 31
PDF
HER2 immunohistochemical scores provide prognostic information for patients with HER2‐type invasive breast cancer
2018 · Yi‐Fang Tsai, Ling‐Ming Tseng, et al. · Histopathology · 25
Nerve‐tumour interaction enhances the aggressiveness of oral squamous cell carcinoma
2019 · Tsung‐Lun Lee, Po‐Hsien Chiu, et al. · Clinical Otolaryngology · 20
Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine
2022 · Jia-Yang Chen, Hsu-Huan Chou, et al. · iScience · 19
Low incidence of BCL‐6 gene alterations for diffuse large B‐cell lymphomas in Taiwan Chinese
2002 · Po‐Min Chen, Muh‐Hwa Yang, et al. · Cancer · 19
PDF
Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study
2017 · Peter Mu‐Hsin Chang, Hsueh‐Ju Lu, et al. · Head & Neck · 16
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study
2011 · Peter Mu-Hsin Chang, Cheng-Hwai Tzeng, et al. · Cancer Chemotherapy and Pharmacology · 14
Molecular Analysis of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of Ocular Adnexa
2001 · Po-Min Chen, Tzeon-Jye Chiou, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 14
Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma
2004 · Po-Min Chen, Muh-Hwa Yang, et al. · Oncology Reports · 13
Efficacy of cetuximab-containing regimens in the treatment of recurrent/metastatic head and neck cancer after progression to immune checkpoint inhibitors
2022 · Cheng-Lun Lai, Tien-Hua Chen, et al. · Journal of the Chinese Medical Association · 12
Snail Augments Nuclear Deformability to Promote Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma
2022 · Yin-Quan Chen, Chen-Yu Hung, et al. · Frontiers in Cell and Developmental Biology · 12
PDF
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study
2026 · Barbara Burtness, Ari J. Rosenberg, et al. · Journal of Clinical Oncology · 11
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study
2026 · Lisa Licitra, Makoto Tahara, et al. · Journal of Clinical Oncology · 11
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma
2022 · Tien-Hua Chen, Yi-Ying Pan, et al. · BMC Cancer · 11
PDF
Non‐Hodgkin lymphoma in elderly patients: Experience at Taipei Veterans General Hospital
2003 · Li‐Yuan Bai, Muh‐Hwa Yang, et al. · Cancer · 8
PDF
Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen
2024 · Muh-Hwa Yang, Tien-Hua Chen, et al. · BMC Cancer · 5
PDF
Abstract CT226: Phase 2 study of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with head and neck squamous cell carcinoma (HNSCC) previously treated with checkpoint inhibitor
2024 · Jameel Muzaffar, Kedar Kirtane, et al. · Cancer Research · 5
GSH as an A‐A Type Allosteric Activator of PKM2: Modulating Cancer Cell Homeostasis and Ferroptosis Susceptibility
2025 · Tsan‐Jan Chen, Chi‐Jen Lo, et al. · Advanced Science · 4
PDF
Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors
2018 · Jen‑Shi Chen, Chun‑Nan Yeh, et al. · Oncology Letters · 4
PDF
Works count: 48
Citation count: 4,019
H-index: 14
I10-index: 21
Year
Topic
Type